Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ Chest infection - pneumococcal pneumonia medication

Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children – Conclusions

Necrotizing pneumonia: an emerging problem in children? – Management

Necrotizing pneumonia: an emerging problem in children? – Antibiotics

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia – 1) P. aeruginosa infection is not suspected

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia – 2) Suspected P. aeruginosa infection

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections – 5. Why are Diagnostics Important for LRTIs? (Antibiotic Stewardship)

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia – Synergistic actions of antibodies with antibiotics mitigate pulmonary tissue damage and edema and prolong the survival of mice with secondary bacterial pneumonia.

Infection with and Carriage of Mycoplasma pneumoniae in Children – Antibiotics

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia – Immunoneutralization of pneumococcal pneumolysin abrogates its pore-forming action on alveolar epithelium.

Megapneumonia Coinfection: pneumococcus, Mycoplasma pneumoniae, and Metapneumovirus – 2. Discussion

The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014 – Materials and methods

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review – On-going clinical trials

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review – New antibiotics

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections – 3. How to Differentiate Bacterial from Viral LRTI at the Point of Care?

Impact of preceding respiratory viral infections on the clinical severity of patients with pneumococcal pneumonia – Antimicrobial treatment and clinical outcome

Community-acquired pneumonia in children — a changing spectrum of disease – Management — recent advances

Viral etiology of pneumonia among severely malnourished under-five children in an urban hospital, Bangladesh – Ethical consideration

Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016 – Therapeutic management

Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy – 5. Treatment

Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls – Pre-publication history

PCR Improves Diagnostic Yield from Lung Aspiration in Malawian Children with Radiologically Confirmed Pneumonia – Study patients and procedures

Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy – 6. Conclusions

Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial – Discussion

Community-acquired pneumonia in children — a changing spectrum of disease – Prevention strategies: new advances

Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial Infection – Discussion